Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
3E Bioventures Capital is a venture capital fund specializing in life sciences, founded in Palo Alto, California. Established to support global health innovators, the firm focuses on the biotech sector, particularly in new drug development, new modalities, and drug discovery platforms. The organization also emphasizes TechBio, which represents the intersection of biology and technology. This focus allows 3E Bioventures to invest in groundbreaking innovations that address unmet medical needs.
The firm operates with a science-driven and entrepreneur-friendly investment philosophy, collaborating closely with companies and research institutions. This approach enables them to identify and support innovations that can significantly impact healthcare. Currently, 3E Bioventures Capital manages a portfolio of 30 companies, reflecting its commitment to advancing the life sciences sector.
3E Bioventures Capital's investment strategy is characterized by its focus on pre-seed, seed, and Series A stages, allowing them to engage with startups at critical points in their development. The firm is dedicated to fostering partnerships that leverage cutting-edge technologies and research, ultimately driving impactful innovations in the biotech field.
3E Bioventures Capital invests primarily in the biotech sector, with a strong emphasis on new drug development and drug discovery platforms. The organization is particularly interested in TechBio innovations that have the potential to disrupt existing paradigms in healthcare. This focus on TechBio allows them to explore the integration of biological sciences with technological advancements, creating opportunities for transformative solutions in medicine.
The firm targets investments at the pre-seed, seed, and Series A stages, which enables them to support early-stage companies that are developing groundbreaking therapies and technologies. 3E Bioventures Capital seeks to partner with entrepreneurs who are committed to addressing significant medical challenges and who possess a strong scientific foundation. Their investment philosophy prioritizes collaboration with portfolio companies, ensuring that they provide not only capital but also strategic guidance and resources to help these companies succeed.
3E Bioventures Capital has built a diverse portfolio of 30 companies, each contributing to advancements in the biotech and healthcare sectors. Notable portfolio companies include:
This diverse portfolio reflects 3E Bioventures Capital's commitment to investing in innovative solutions that address critical healthcare challenges. Each company is positioned to contribute to advancements in their respective fields, showcasing the firm's strategic focus on biotech and healthcare.
To pitch to 3E Bioventures Capital, founders should use the contact information available on their website. A concise pitch deck is essential, highlighting the scientific foundation of the innovation, market potential, and the team’s qualifications. The firm appreciates well-structured presentations that clearly articulate the problem being solved and the proposed solution.
Response times can vary, but founders should expect to hear back within a few weeks. Warm introductions are preferred, as they can facilitate a more favorable review process.
What are 3E Bioventures Capital's investment criteria?
The firm focuses on biotech innovations, particularly in new drug development and drug discovery platforms. They seek companies that are addressing unmet medical needs and have a strong scientific foundation.
How can I apply or pitch to 3E Bioventures Capital?
Founders can reach out through the firm's website or contact them directly at their Palo Alto office. A well-prepared pitch deck highlighting the scientific basis of the innovation and the market potential is essential.
What makes 3E Bioventures Capital different from other venture capital firms?
3E Bioventures Capital emphasizes a science-driven and entrepreneur-friendly investment philosophy. They prioritize collaboration with portfolio companies and research institutions to enhance the development of innovative solutions.
What is the geographic scope of 3E Bioventures Capital's investments?
The firm invests globally, with a particular focus on North America, allowing them to tap into a wide range of biotech innovations.
What is the typical check size for investments?
While specific check sizes are not disclosed, 3E Bioventures Capital typically invests at the pre-seed, seed, and Series A stages, which suggests a range that aligns with early-stage funding needs.
What is 3E Bioventures Capital's involvement post-investment?
The firm actively collaborates with its portfolio companies, providing strategic guidance and resources to help them navigate challenges and accelerate growth.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.